A5101643391- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Blood disorders and treatments
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Neutropenia and Cancer Infections
- Inflammatory Myopathies and Dermatomyositis
- Public Health and Environmental Issues
- CNS Lymphoma Diagnosis and Treatment
- Genomics and Rare Diseases
- Hematological disorders and diagnostics
- Atrial Fibrillation Management and Outcomes
- Multiple Myeloma Research and Treatments
- Blood groups and transfusion
- HER2/EGFR in Cancer Research
- Educational Practices and Policies
- Maternal and Perinatal Health Interventions
- History of Education in Spain
- Lymphoma Diagnosis and Treatment
- Cardiovascular Function and Risk Factors
- Muscle Physiology and Disorders
- Social Sciences and Policies
- Oral Health Pathology and Treatment
- Autoimmune Neurological Disorders and Treatments
Pontificia Universidad Javeriana
1988-2025
University of Cauca
2004-2024
Teradata (United Kingdom)
2023
Casio (Japan)
2023
Asociación Colombiana de Hematología y Oncología
2023
Semmelweis University
2023
Copernicus Memorial Hospital
2023
Mansoura University
2023
Asociación Colombiana de Gastroenterología
2023
There is a limited information available on the clinical characteristics, treatment patterns and outcomes older patients diagnosed with Acute Myeloid Leukemia (AML) in Latin-America. This multicenter retrospective study analyzed 269 over 60 years of age AML Colombia, using data from RENEHOC-PETHEMA registry, 2009 to 2023. The median at diagnosis was 70 (Range:60–98), 55% were men, 61% had an ECOG < 2, 75.5% de novo AML. FLT3-ITD or NPM1 mutations performed 23.4% 15.6% patients, detected...
<title>Abstract</title> There is a limited information available on the clinical characteristics, treatment patterns and outcomes older patients diagnosed with Acute Myeloid Leukemia (AML) in Latin-America. This multicenter retrospective study analyzed 269 over 60 years of age AML Colombia, using data from RENEHOC-PETHEMA registry, 2009 to 2023. The median at diagnosis was 70 (Range: 60–98), 55% were men, 61% had an ECOG < 2, 75.5% de novo AML. FLT3-ITD or NPM1 mutations performed 23.4%...
Introducción: Los medicamentos antitiroideos son una de las alternativas terapéuticas en el tratamiento la enfermedad Graves. Sin embargo, puede generar efectos adversos severos aunque poco frecuentes a nivel hematológico como anemia aplásica, cual se ha asociado con altas dosis estos medicamentos, reversión esta afección hematológica ante retiro del medicamento. Descripción caso: Mujer 38 años antecedente Graves Metimazol, quien consulta por síntomas epistaxis anterior difícil control,...
Objetivo: Reportar un caso de gammapatía monoclonal significado indeterminado con eventos trombóticos y cardiovasculares mayores.
Objetivo: describir las características clínicas y biológicas de pacientes con LMA recaída refractaria en el Registro PETHEMA-RENEHOC. Metodología: estudio retrospectivo multicéntrico, análisis secundario datos basados Epidemiológico Enfermedades Hematológicas Oncológicas Colombia (RENEHOC). Fueron elegibles los mayores o iguales a 18 años si su fue 1 2 ciclos inducción presentaron después alcanzar respuesta completa.
Objetivos: analizamos retrospectivamente los desenlaces de pacientes registrados en el RENEHOC que requirieron cambio a una segunda línea tratamiento. El objetivo principal del estudio fue comparar dasatinib versus nilotinib, usados como terapia intolerantes o resistentes primera línea. Materiales y métodos: utiliza herramienta electrónica captura datos. Este informe analiza forma retrospectiva la información 584 con LMC hasta agosto 2022, 16 centros 6 ciudades país, centrados estadísticas...
Topic: 4. Acute myeloid leukemia - Clinical Background: (AML) is a heterogeneous and aggressive malignancy. AML characterized by clonal proliferation of precursors with reduced capacity to differentiate into more mature cellular elements. considered the most common type acute in adults, higher incidence adults older than 65 years, mean age 58 years (IQR: 38 – 72). Aims: The aim this study was determine factors associated Colombia. Methods: RENEHOC bidirectional (retrospective prospective)...
La trombocitopenia inmune primaria es un trastorno autoinmune adquirido, caracterizado por una destrucción plaquetaria excesiva, derivada de la producción anticuerpos contra membrana plaquetaria, conllevando a alto riesgo hemorragia para el paciente. Actualmente, piedra angular del tratamiento sigue siendo uso agentes primera línea como los glucocorticoides y inmunoglobulina intravenosa. Sin embargo, en algunos casos pacientes pueden ser refractarios estos, con requerimiento terapias segunda...
Background: The overall survival (OS) of acute myeloid leukemia (AML) decreases as age increases among patients. There are clinical and biological differences in AML older Even with actual treatments, 70% patients than 65 years will die their disease within 1 year diagnosis. Aims: Our aim was to characterize the elderly (>65 old) leukaemia (AML), who were attended 13 health institutions Colombia, from 2009 2021, including RENEHOC (online platform) PETHEMA date base (Spanish Program for...
In addition to signs and symptoms at sites of primary metastatic disease, cancer can cause manifestations in remote that are not directly affected by any focus disease. Such malignancy collectivelly known as paraneoplastic phenomenon. Muscular consist slight severe usually proximal wasting weakness. our laboratory we described the ultrastructural pathology skeletal muscle phenomenon patients with bronchogenic cervix carcinoma. these studies a brief report on capillary alterations was made....